• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体因子 H 相关蛋白(CFHRs)。

Complement factor H related proteins (CFHRs).

机构信息

Department of Infection Biology, Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

出版信息

Mol Immunol. 2013 Dec 15;56(3):170-80. doi: 10.1016/j.molimm.2013.06.001. Epub 2013 Jul 3.

DOI:10.1016/j.molimm.2013.06.001
PMID:23830046
Abstract

Factor H related proteins comprise a group of five plasma proteins: CFHR1, CFHR2, CFHR3, CFHR4 and CFHR5, and each member of this group binds to the central complement component C3b. Mutations, genetic deletions, duplications or rearrangements in the individual CFHR genes are associated with a number of diseases including atypical hemolytic uremic syndrome (aHUS), C3 glomerulopathies (C3 glomerulonephritis (C3GN), dense deposit disease (DDD) and CFHR5 nephropathy), IgA nephropathy, age related macular degeneration (AMD) and systemic lupus erythematosus (SLE). Although complement regulatory functions were attributed to most of the members of the CFHR protein family, the precise role of each CFHR protein in complement activation and the exact contribution to disease pathology is still unclear. Recent publications show that CFHR proteins form homo- as well as heterodimers. Genetic abnormalities within the CFHR gene locus can result in hybrid proteins with affected dimerization or recognition domains which cause defective functions. Here we summarize the recent data about CFHR genes and proteins in order to better understand the role of CFHR proteins in complement activation and in complement associated diseases.

摘要

因子 H 相关蛋白包含一组五种血浆蛋白:CFHR1、CFHR2、CFHR3、CFHR4 和 CFHR5,该组的每个成员都与中央补体成分 C3b 结合。个体 CFHR 基因中的突变、遗传缺失、重复或重排与多种疾病相关,包括非典型溶血性尿毒综合征(aHUS)、C3 肾小球病(C3 肾小球肾炎(C3GN)、致密沉积物病(DDD)和 CFHR5 肾病)、IgA 肾病、年龄相关性黄斑变性(AMD)和系统性红斑狼疮(SLE)。尽管补体调节功能归因于 CFHR 蛋白家族的大多数成员,但每个 CFHR 蛋白在补体激活中的精确作用以及对疾病发病机制的确切贡献仍不清楚。最近的出版物表明,CFHR 蛋白形成同源二聚体和异源二聚体。CFHR 基因座内的遗传异常可导致杂合蛋白的二聚化或识别域受到影响,从而导致功能缺陷。在这里,我们总结了 CFHR 基因和蛋白的最新数据,以便更好地了解 CFHR 蛋白在补体激活和补体相关疾病中的作用。

相似文献

1
Complement factor H related proteins (CFHRs).补体因子 H 相关蛋白(CFHRs)。
Mol Immunol. 2013 Dec 15;56(3):170-80. doi: 10.1016/j.molimm.2013.06.001. Epub 2013 Jul 3.
2
Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.血浆中补体因子H相关(CFHR)蛋白的特征分析揭示了与非典型溶血尿毒综合征相关的CFHR1新基因变异。
Blood. 2009 Nov 5;114(19):4261-71. doi: 10.1182/blood-2009-05-223834. Epub 2009 Sep 10.
3
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征患者中,补体因子 H 自身抗体与 CFHR1、CFHR3、CFHR4 的缺失以及 CFH、CFI、CD46 和 C3 中的突变相关。
Blood. 2010 Jan 14;115(2):379-87. doi: 10.1182/blood-2009-05-221549. Epub 2009 Oct 27.
4
A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.一种新型 CFHR1-CFHR5 杂合导致家族性显性 C3 肾小球病。
Kidney Int. 2017 Oct;92(4):876-887. doi: 10.1016/j.kint.2017.04.025. Epub 2017 Jul 18.
5
Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.基因变异为肾脏疾病非典型溶血尿毒症综合征和 C3 肾小球病的发病机制提供了新见解。
J Am Soc Nephrol. 2020 Feb;31(2):241-256. doi: 10.1681/ASN.2019050515. Epub 2020 Jan 24.
6
Copy number variation in the complement factor H-related genes and age-related macular degeneration.补体因子H相关基因的拷贝数变异与年龄相关性黄斑变性
Mol Vis. 2011;17:2080-92. Epub 2011 Aug 6.
7
Factor H family proteins and human diseases.补体因子H家族蛋白与人类疾病。
Trends Immunol. 2008 Aug;29(8):380-7. doi: 10.1016/j.it.2008.04.008. Epub 2008 Jul 2.
8
The role of complement in AMD.补体系统在 AMD 中的作用。
Adv Exp Med Biol. 2010;703:9-24. doi: 10.1007/978-1-4419-5635-4_2.
9
Complement factor H-related hybrid protein deregulates complement in dense deposit disease.补体因子 H 相关杂合蛋白在致密物沉积病中调控补体。
J Clin Invest. 2014 Jan;124(1):145-55. doi: 10.1172/JCI71866. Epub 2013 Dec 16.
10
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.非典型溶血性尿毒症综合征中的H因子自身抗体与CFHR1/CFHR3缺乏相关。
Blood. 2008 Feb 1;111(3):1512-4. doi: 10.1182/blood-2007-09-109876. Epub 2007 Nov 15.

引用本文的文献

1
Plasma complement proteins as biomarkers and therapeutic targets in chronic kidney disease: a Mendelian randomization analysis.血浆补体蛋白作为慢性肾脏病的生物标志物和治疗靶点:孟德尔随机化分析
Ren Fail. 2025 Dec;47(1):2525473. doi: 10.1080/0886022X.2025.2525473. Epub 2025 Jul 17.
2
Identifying novel biomarkers for ankylosing spondylitis through proteomic profiling of serum-derived extracellular vesicles.通过血清来源的细胞外囊泡蛋白质组学分析鉴定强直性脊柱炎的新型生物标志物。
Clin Exp Med. 2025 Jul 1;25(1):227. doi: 10.1007/s10238-025-01718-8.
3
Analysis of human factor H-related gene and protein expressed in rheumatoid arthritis synovium identifies a novel mechanism promoting dysregulated complement pathway activation.
对类风湿性关节炎滑膜中表达的人补体因子H相关基因和蛋白质的分析揭示了一种促进补体途径激活失调的新机制。
Sci Rep. 2025 Jun 4;15(1):19633. doi: 10.1038/s41598-025-03589-1.
4
Pathogenesis of Focal Segmental Glomerulosclerosis and Minimal Change Disease: Insights from Glomerular Proteomics.局灶节段性肾小球硬化症和微小病变病的发病机制:肾小球蛋白质组学的见解
Life (Basel). 2025 Mar 23;15(4):527. doi: 10.3390/life15040527.
5
Association of Complement Proteins with C Reactive Protein in Non-Obese Women with and Without Polycystic Ovary Syndrome.非肥胖多囊卵巢综合征患者与非多囊卵巢综合征患者中补体蛋白与C反应蛋白的关联
Int J Mol Sci. 2025 Mar 26;26(7):3008. doi: 10.3390/ijms26073008.
6
Development and Characterization of Novel ELISAs for the Specific Quantification of the Factor H-Related Proteins 2, 3, 4, and 5.用于特异性定量因子H相关蛋白2、3、4和5的新型酶联免疫吸附测定法的开发与特性分析
J Innate Immun. 2025;17(1):226-243. doi: 10.1159/000545139. Epub 2025 Mar 26.
7
The role of the complement system in Shiga toxin-associated hemolytic uremic syndrome.补体系统在志贺毒素相关溶血尿毒综合征中的作用。
Pediatr Nephrol. 2025 May;40(5):1711-1722. doi: 10.1007/s00467-024-06629-6. Epub 2025 Jan 10.
8
Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma.靶向促肾上腺皮质激素释放激素结合蛋白和补体因子H相关蛋白3的创新双信使核糖核酸-脂质纳米颗粒疗法用于增强肝细胞癌治疗
Int J Nanomedicine. 2024 Dec 7;19:13183-13199. doi: 10.2147/IJN.S498065. eCollection 2024.
9
C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation.C3肾小球病:一种由替代途径失调介导的肾脏疾病。
Front Nephrol. 2024 Oct 29;4:1460146. doi: 10.3389/fneph.2024.1460146. eCollection 2024.
10
Correlating plasma protein profiles with symptomatology and treatment response in acute phase and early remission of major depressive disorder.在重度抑郁症急性期和早期缓解期,将血浆蛋白谱与症状学及治疗反应相关联。
Front Psychiatry. 2024 Sep 17;15:1425552. doi: 10.3389/fpsyt.2024.1425552. eCollection 2024.